ME

MEDINET Co., Ltd.

A CDMO for cell therapy and regenerative medicine development & manufacturing.

2370 | T

Overview

Corporate Details

ISIN(s):
JP3920990003
LEI:
Country:
Japan
Address:
品川区勝島一丁目5番21号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

MEDINET Co., Ltd. is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the regenerative medicine and cell therapy sectors. Since its establishment in 1999, the company has provided comprehensive, one-stop solutions across the entire value chain, from pre-clinical research and technology transfer to manufacturing and commercial launch. Key services include process development, quality control, quality assurance, and logistics. MEDINET operates an advanced cell processing facility compliant with Japanese, US, and European GCTP standards, leveraging its extensive experience and deep expertise in Japan's regulatory framework to support its clients' development and manufacturing needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-14 08:33
Report Publication Announcement
確認書
Japanese 8.3 KB
2025-05-14 08:32
Interim / Quarterly Report
半期報告書-第30期(2024/10/01-2025/09/30)
Japanese 204.7 KB
2024-12-26 04:04
AGM Information
臨時報告書
Japanese 25.2 KB
2024-12-18 07:40
Registration Form
確認書
Japanese 8.3 KB
2024-12-18 07:38
Governance Information
内部統制報告書-第29期(2023/10/01-2024/09/30)
Japanese 21.6 KB
2024-12-18 07:35
Annual Report
有価証券報告書-第29期(2023/10/01-2024/09/30)
Japanese 1.3 MB
2024-05-14 08:02
Report Publication Announcement
確認書
Japanese 8.3 KB
2024-05-14 08:00
Quarterly Report
四半期報告書-第29期第2四半期(2024/01/01-2024/03/31)
Japanese 200.2 KB
2024-02-13 07:04
Report Publication Announcement
確認書
Japanese 8.3 KB
2024-02-13 07:01
Quarterly Report
四半期報告書-第29期第1四半期(2023/10/01-2023/12/31)
Japanese 152.4 KB
2023-12-21 07:03
Registration Form
確認書
Japanese 8.3 KB
2023-12-21 07:02
Governance Information
内部統制報告書-第28期(2022/10/01-2023/09/30)
Japanese 21.7 KB
2023-12-21 07:01
Annual Report
有価証券報告書-第28期(2022/10/01-2023/09/30)
Japanese 1.3 MB
2023-08-10 08:02
Report Publication Announcement
確認書
Japanese 8.3 KB
2023-08-10 08:00
Quarterly Report
四半期報告書-第28期第3四半期(2023/04/01-2023/06/30)
Japanese 157.7 KB

Automate Your Workflow. Get a real-time feed of all MEDINET Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MEDINET Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MEDINET Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Denali Therapeutics Inc. Logo
Developing therapies for neurodegenerative diseases that cross the blood-brain barrier.
United States of America
DNLI
Dermapharm Holding SE Logo
Manufactures patent-free branded pharmaceuticals & healthcare products for niche markets.
Germany
DMP
Dermata Therapeutics, Inc. Logo
Develops OTC skin treatments using a unique delivery technology from freshwater sponges.
United States of America
DRMA
Design Therapeutics, Inc. Logo
Develops small molecule genomic medicines to treat serious genetic diseases by modulating genes.
United States of America
DSGN
Deutsche Biotech Innovativ AG Logo
Develops biomarker-driven therapeutics and diagnostics for serious diseases with unmet needs.
Germany
DBI
DEVA HOLDİNG A.Ş. Logo
Global manufacturer of human/veterinary pharmaceuticals, APIs, and medical ampoules.
Spain
DEVA
Devyser Diagnostics Logo
Develops & sells genetic DNA test kits for labs in oncology, transplant & reproductive health.
Sweden
DVYSR
DexTech Medical AB Logo
Developing pharmaceuticals for urological oncology using its proprietary GuaDex technology platform.
Sweden
DEX
DiaMedica Therapeutics Inc. Logo
Developing a novel protein therapy for acute ischemic stroke and preeclampsia.
United States of America
DMAC
Diamyd Medical AB (publ) Logo
Developing precision immunotherapies to preserve insulin in autoimmune diabetes.
Sweden
DMYD

Talk to a Data Expert

Have a question? We'll get back to you promptly.